查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587083

全球 HbA1c 检测设备市场评估：按设备类型、技术、最终用户、地区、机会、预测（2017-2031 年）

HbA1c Testing Devices Market Assessment, By Type of Devices, By Technology, By End-user, By Region Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 241 Pages | 商品交期: 3-5个工作天内

价格

全球 HbA1c 检测设备市场规模预计将从 2023 年的 23.72 亿美元增至 2031 年的 42.3356 亿美元，预计 2024-2031 年的复合年增长率为 7.51%。由于糖尿病盛行率的增加以及投资者和市场公司的兴趣日益浓厚，预计 HbA1c 检测设备的市场需求将在预测年内呈指数级增长。

由于糖尿病在全球范围内的迅速传播，该市场提供了许多成长机会。许多醣尿病病例，尤其是第 2 型糖尿病病例正在被通报，人们要求对这种疾病进行有效的定期监测。因此，HbA1c 测试已成为测量长期血糖水平的必要条件，其中包括即时检测设备等技术进步。在低收入和中等收入国家，糖尿病的盛行率非常高。事实上，大约四分之三的受影响者生活在低收入和中等收入国家。糖尿病是一种慢性疾病，是由于身体无法产生胰岛素或无法有效利用胰岛素所引起的。结果，体内血糖水平升高，导致更严重的併发症，如心血管疾病、肾臟疾病和视力问题。超过 4.22 亿人患有糖尿病，其中大多数生活在低收入和中等收入国家。其中，每年约有 150 万人死于糖尿病。例如，2024 年 2 月，HemoCue 宣布与诺和诺德 (Novo Nordisk A/S) 合作，以改善低收入和中等收入国家 1 型糖尿病儿童的护理点诊断测试。

本报告研究和分析了全球 HbA1c 检测设备市场，提供市场规模和预测、市场动态以及主要参与者的状况。

目录

第1章专案范围与定义

第2章研究方法

第 3 章执行摘要

第4章全球 HbA1c 检测设备市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
  • 市占率分析与预测
    • 依装置类型
    • 按技术
    • 按最终用户
    • 按地区
    • 市占率分析：按公司划分（金额）（前 5 名公司及其他 - 2023 年）
  • 市场地图分析（2023 年）
    • 依装置类型
    • 按技术
    • 按最终用户
    • 按地区

第5章北美 HbA1c 检测设备市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
  • 市占率分析与预测
    • 依装置类型
    • 按技术
    • 按最终用户
    • 分享：依国家/地区
  • 每个国家市场的评估
    • 美国 HbA1c 检测设备市场前景（2017-2031）
    • 加拿大
    • 墨西哥

第6章 欧洲 HbA1c 侦测设备市场展望（2017-2031 年）

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第7章亚太地区 HbA1c 检测设备市场展望（2017-2031）

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第8章南美HbA1c检测设备市场展望（2017-2031）

  • 巴西
  • 阿根廷

第9章中东与非洲HbA1c检测设备市场前景（2017-2031）

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 以色列

第10章供需分析

第11章价值链分析

第12章波特五力分析

第 13 章 PESTLE 分析

第 14 章市场动态

  • 市场推动因素
  • 市场课题

第15章市场趋势与发展

第 16 章监理架构与创新

  • 监理机关的核准
  • 创新

第17章专利状况

第 18 章个案研究

第19章竞争态势

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名的公司的 SWOT 分析
  • 前10名主要企业状况
    • Abbott.
    • Bio-Rad Laboratories, Inc.
    • Trinity Biotech
    • Siemens Healthineers AG
    • F.Hoffmann-La Roche Ltd
    • Danaher Corporation
    • SAKAE CO, LTD.
    • ARKRAY, Inc.
    • HUMAN Gesellschaft fur Biochemica und Diagnostica
    • Menarini Diagnostics s.r.l

第 20 章策略建议

第21章关于我们公司，免责声明

Product Code: MX12206

Global HbA1c testing devices market is projected to witness a CAGR of 7.51% during the forecast period 2024-2031, growing from USD 2372 million in 2023 to USD 4233.56 million in 2031. The market demand for HbA1c testing devices is anticipated to thrive drastically in the forecast years due to the increasing prevalence of diabetes and the growing interest of investors and market players.

The global HbA1c testing device market is thus witnessing many growth opportunities due to the fast spreading of diabetes across the globe. More cases of diabetes are being reported, especially type 2 cases, for which people look for effective and regular monitoring for this disease. Thus, HbA1c testing becomes a necessity-measuring long-term blood glucose levels, including technological advancements such as point-of-care testing devices. The prevalence of diabetes is very high in low- and middle-income countries. In fact, about three-quarters of the affected people reside in low- and middle-income countries. Diabetes is a chronic condition that results from a lack of production or ineffective use of insulin by the body. As a result, the blood glucose level (blood sugar level) increases in the body, which leads to even more severe complications such as cardiovascular diseases, kidney disease, and vision problems. More than 422 million people suffer from diabetes, of which a vast majority live in low- and middle-income countries. Out of these, around 1.5 million die each year due to diabetes. For instance, in February 2024, HemoCue announced a partnership with Novo Nordisk A/S to improve point-of-care diagnostic testing for children with type 1 diabetes in low- and middle-income countries.

Increased Prevalence of Diabetes to Support HbA1c Testing Devices Market Growth

The increasing incidence of diabetes is driving the market for HbA1c testing devices. Rising burdens, especially due to changing lifestyle, aging population, and increasing obesity rates, have spurred demand for adequate management tools for diabetes. The HbA1c testing device measures blood glucose levels over the long term to evaluate the efficiency of a treatment regime and the potential risks of complications. As the number of diabetes patients increases, healthcare providers rely more on these tests for routine diabetes care to advance diabetes management. The devices have become necessary for having steady and accurate monitoring in clinical and home settings, driving better outcomes for patients and better management of the disease at large. For instance, in April 2023, FIND announced a partnership with Abbott, i-SENS, Inc., and Siemens Healthineers AG to improve hemoglobin (HbA1c) testing for diabetes diagnosis and management by offering a special price for point-of-care test kits for low and middle-income countries (LMICs).

Technological Advancement in Testing Devices to Drive Market Growth

Advancements in the technology of devices used for HbA1c testing have played a significant role in the growth of this market. Technological advancements have made the tests more accurate and convenient to access. Innovations such as point-of-care (POC) devices have allowed testing outside traditional laboratories, which could provide immediate results in minutes. Portable analyzers that are friendly to the user have made it easier for healthcare providers to monitor the glycemic control of their patients in real time and improve their decisions based on clinical judgment. Furthermore, developing automated systems and integrated platforms with HbA1c testing that integrate with other diagnostic procedures helps streamline the procedure and reduce the number of visits to the healthcare provider to conduct the test. Such advancements improve patient outcomes by making regular HbA1c monitoring available, even in hard-to-reach or underserved areas, and support increased demand for personalized diabetes management. For instance, in July 2024, EKF Diagnostics Holdings plc, a global diagnostics business, announced the launch of its new Biosen C-Line, an advanced version of its industry-leading rapid benchtop glucose and lactate analyzer. The Biosen C-Line analyzer measures glucose and lactate levels in whole blood, plasma, and serum using enzymatic sensor technology to give precise results.

Point-of-Care Testing Devices Segment to Dominate the HbA1c Testing Devices Market Share

The point-of-care (POC) testing devices segment is anticipated to dominate the market of HbA1c testing devices primarily due to the rising demand for fast, accessible, and reliable diabetic management solutions. POC testing devices enable one to carry out HbA1c testing on-site and thereby provide healthcare providers and patients with real-time information in various settings, such as clinics, pharmacies, and home settings. This gives an opportunity for the modification of treatment plans in a timely manner, thus providing better patient outcomes and satisfaction. With patients continuously getting affected with diabetes around the globe, POC testing devices will play an important role in the effective management of diabetes and hence prove to be a big growth driver in the HbA1c testing device market. For instance, in December 2023, F. Hoffmann-La Roche Ltd signed a deal to acquire LumiraDx point-of-care testing technology for USD 295 million, with an extra USD 55 million committed to supporting Lumira's platform development until the acquisition is finalized.

North America to Dominate the HbA1c Testing Devices Market Share

North America leads the share of the global HbA1c testing devices market due to the high prevalence of diabetes, higher healthcare expenditure, and advanced healthcare infrastructure in the region. Driving factors behind this region's growth are strong awareness of diabetes management, early adoption of advanced diagnostic technologies, and a well-established healthcare system. Moreover, a growing obese population and an aging population also require more HbA1c tests because the control of this condition requires timely monitoring of blood glucose levels. So, North America leads the HbA1c testing device market due to these technological innovations and strategic tie-ups by the key players in this industry. For instance, in June 2024, Abbott announced receiving approval from the U.S. Food and Drug Administration (FDA) for two new over-the-counter continuous glucose monitoring (CGM) systems, Lingo and Libre Rio. Lingo targets general consumers focused on improving overall health and wellness. Libre Rio is tailored for adults with Type 2 diabetes who manage their condition through lifestyle changes and do not use insulin.

Future Market Scenario (2024-2031F)

The HbA1c testing device market is expected to grow significantly in the future because of a continuously increasing rate of diabetes across the globe, increased focus on preventive care, and new developments in diagnostic technology. A better understanding and higher adoption rate of point-of-care devices will drive demand. The high ease of use, greater accuracy in testing, and compatibility with digital health platforms for the management of diseases will allow for greater ease of accessibility and patient engagement in the market. In particular, emerging economies with expanding healthcare infrastructure and increased healthcare spending will provide significant market opportunities. Overall, the market is likely to expand due to continuous R&D, strategic alliances, and regulatory approvals to improve diabetes monitoring and patient outcomes. For instance, in December 2023, Tosoh Bioscience partnership with Sysmex Corporation America to connect its HLC-723G8 automated glycohemoglobin analyzers with Sysmex's XN-9000 and XN-9100 hematology systems across the U.S., Latin America, and Canada. This collaboration aims to expand Tosoh's HbA1c testing capabilities for high-volume labs and enhance automation in HbA1c testing.

Key Players Landscape and Outlook

The HbA1c testing devices market is highly dynamic and driven by many key market players. Market activity reported in recent years includes business agreements and regulatory approvals of market players' products. The market has witnessed many business activities, such as strategic mergers, acquisitions, and collaborations.

For instance, in February 2024, Dexcom, Inc. launched Dexcom ONE+ in Spain, Belgium, and Poland-a customizable, real-time continuous glucose monitoring (CGM) system solution wearable in three body locations. The Dexcom ONE+ system includes a water-resistant sensor, a transmitter for real-time glucose data, and a smartphone-compatible app for convenient monitoring.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global HbA1c Testing Devices Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Type of Devices
      • 4.2.1.1. Laboratory-based Testing Devices
      • 4.2.1.2. Point-of-Care Testing Devices
    • 4.2.2. By Technology
      • 4.2.2.1. Immunoassay
      • 4.2.2.2. Enzymatic Assays
      • 4.2.2.3. Chromatography
      • 4.2.2.4. High-performance Liquid Chromatography
      • 4.2.2.5. Boronate Affinity Chromatography
      • 4.2.2.6. Others
    • 4.2.3. By End-user
      • 4.2.3.1. Hospitals and Clinics
      • 4.2.3.2. Diagnostic Laboratories
      • 4.2.3.3. Homecare Settings
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Type of Devices
    • 4.3.2. By Technology
    • 4.3.3. By End-user
    • 4.3.4. By Region

5. North HbA1c Testing Devices Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Type of Devices
      • 5.2.1.1. Laboratory-based Testing Devices
      • 5.2.1.2. Point-of-Care Testing Devices
    • 5.2.2. By Technology
      • 5.2.2.1. Immunoassay
      • 5.2.2.2. Enzymatic Assays
      • 5.2.2.3. Chromatography
      • 5.2.2.4. High-performance Liquid Chromatography
      • 5.2.2.5. Boronate Affinity Chromatography
      • 5.2.2.6. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Hospitals and Clinics
      • 5.2.3.2. Diagnostic Laboratories
      • 5.2.3.3. Homecare Settings
      • 5.2.3.4. Others
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States HbA1c Testing Devices Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Type of Devices
          • 5.3.1.2.1.1. Laboratory-based Testing Devices
          • 5.3.1.2.1.2. Point-of-Care Testing Devices
        • 5.3.1.2.2. By Technology
          • 5.3.1.2.2.1. Immunoassay
          • 5.3.1.2.2.2. Enzymatic Assays
          • 5.3.1.2.2.3. Chromatography
          • 5.3.1.2.2.4. High-performance Liquid Chromatography
          • 5.3.1.2.2.5. Boronate Affinity Chromatography
          • 5.3.1.2.2.6. Others
        • 5.3.1.2.3. By End-user
          • 5.3.1.2.3.1. Hospitals and Clinics
          • 5.3.1.2.3.2. Diagnostic Laboratories
          • 5.3.1.2.3.3. Homecare Settings
          • 5.3.1.2.3.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe HbA1c Testing Devices Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific HbA1c Testing Devices Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America HbA1c Testing Devices Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa HbA1c Testing Devices Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Market Dynamics

  • 14.1. Market Drivers
  • 14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

  • 16.1. Regulatory Approvals
  • 16.2. Innovations

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

  • 19.1. Competition Matrix of Top 5 Market Leaders
  • 19.2. SWOT Analysis for Top 5 Players
  • 19.3. Key Players Landscape for Top 10 Market Players
    • 19.3.1. Abbott.
      • 19.3.1.1. Company Details
      • 19.3.1.2. Key Management Personnel
      • 19.3.1.3. Products and Services
      • 19.3.1.4. Financials (As Reported)
      • 19.3.1.5. Key Market Focus and Geographical Presence
      • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 19.3.2. Bio-Rad Laboratories, Inc.
    • 19.3.3. Trinity Biotech
    • 19.3.4. Siemens Healthineers AG
    • 19.3.5. F.Hoffmann-La Roche Ltd
    • 19.3.6. Danaher Corporation
    • 19.3.7. SAKAE CO, LTD.
    • 19.3.8. ARKRAY, Inc.
    • 19.3.9. HUMAN Gesellschaft fur Biochemica und Diagnostica
    • 19.3.10. Menarini Diagnostics s.r.l

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 3. Global HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 4. Global HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 5. Global HbA1c Testing Devices Market Share (%), By Region, 2017-2031F
  • Figure 6. North America HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 7. North America HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 8. North America HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 9. North America HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 10. North America HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
  • Figure 11. United States HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 12. United States HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 13. United States HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 14. United States HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 15. Canada HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 16. Canada HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 17. Canada HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 18. Canada HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 19. Mexico HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 20. Mexico HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 21. Mexico HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 22. Mexico HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 23. Europe HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 24. Europe HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 25. Europe HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 26. Europe HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 27. Europe HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
  • Figure 28. Germany HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 29. Germany HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 30. Germany HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 31. Germany HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 32. France HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 33. France HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 34. France HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 35. France HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 36. Italy HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 37. Italy HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 38. Italy HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 39. Italy HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 40. United Kingdom HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 41. United Kingdom HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 42. United Kingdom HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 43. United Kingdom HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 44. Russia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 45. Russia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 46. Russia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 47. Russia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 48. Netherlands HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 49. Netherlands HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 50. Netherlands HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 51. Netherlands HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 52. Spain HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Spain HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 54. Spain HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 55. Spain HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 56. Turkey HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 57. Turkey HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 58. Turkey HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 59. Turkey HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 60. Poland HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 61. Poland HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 62. Poland HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 63. Poland HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. South America HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 65. South America HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 66. South America HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 67. South America HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 68. South America HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
  • Figure 69. Brazil HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 70. Brazil HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 71. Brazil HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 72. Brazil HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 73. Argentina HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 74. Argentina HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 75. Argentina HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 76. Argentina HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 77. Asia-Pacific HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 78. Asia-Pacific HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 79. Asia-Pacific HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 80. Asia-Pacific HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 81. Asia-Pacific HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
  • Figure 82. India HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 83. India HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 84. India HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 85. India HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 86. China HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 87. China HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 88. China HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 89. China HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 90. Japan HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 91. Japan HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 92. Japan HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 93. Japan HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 94. Australia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 95. Australia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 96. Australia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 97. Australia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 98. Vietnam HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 99. Vietnam HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 100. Vietnam HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 101. Vietnam HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 102. South Korea HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 103. South Korea HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 104. South Korea HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 105. South Korea HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 106. Indonesia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 107. Indonesia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 108. Indonesia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 109. Indonesia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 110. Philippines HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 111. Philippines HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 112. Philippines HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 113. Philippines HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 114. Middle East & Africa HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 115. Middle East & Africa HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 116. Middle East & Africa HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 117. Middle East & Africa HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 118. Middle East & Africa HbA1c Testing Devices Market Share (%), By Country, 2017-2031F
  • Figure 119. Saudi Arabia HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 120. Saudi Arabia HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 121. Saudi Arabia HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 122. Saudi Arabia HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 123. UAE HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 124. UAE HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 125. UAE HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 126. UAE HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 127. South Africa HbA1c Testing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 128. South Africa HbA1c Testing Devices Market Share (%), By Type of Devices, 2017-2031F
  • Figure 129. South Africa HbA1c Testing Devices Market Share (%), By Technology, 2017-2031F
  • Figure 130. South Africa HbA1c Testing Devices Market Share (%), By End-user, 2017-2031F
  • Figure 131. By Type of Devices Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 132. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 133. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 134. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023